{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "marketState": "REGULAR", "regularMarketChangePercent": 2.1645, "regularMarketPrice": 0.118, "exchange": "FRA", "shortName": "BIOSENIC S.A.", "longName": "BioSenic S.A.", "messageBoardId": "finmb_333665998", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketTime": 1683871387, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.48, "sharesOutstanding": 124009000, "bookValue": -0.464, "fiftyDayAverage": 0.115866, "fiftyDayAverageChange": 0.0021340027, "fiftyDayAverageChangePercent": 0.018417852, "twoHundredDayAverage": 0.143168, "twoHundredDayAverageChange": -0.025168002, "twoHundredDayAverageChangePercent": -0.17579348, "marketCap": 14633062, "priceToBook": -0.25431034, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "prevName": "Bone Therapeutics SA", "nameChangeDate": "2023-05-11", "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1423638000000, "priceHint": 4, "regularMarketChange": 0.0024999976, "regularMarketDayHigh": 0.118, "regularMarketDayRange": "0.118 - 0.118", "regularMarketDayLow": 0.118, "regularMarketVolume": 1267, "regularMarketPreviousClose": 0.1155, "bid": 0.105, "ask": 0.138, "bidSize": 200, "askSize": 200, "fullExchangeName": "Frankfurt", "financialCurrency": "EUR", "regularMarketOpen": 0.118, "averageDailyVolume3Month": 216, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 0.044200003, "fiftyTwoWeekLowChangePercent": 0.59891605, "fiftyTwoWeekRange": "0.0738 - 0.31", "fiftyTwoWeekHighChange": -0.192, "fiftyTwoWeekHighChangePercent": -0.61935484, "fiftyTwoWeekLow": 0.0738, "fiftyTwoWeekHigh": 0.31, "symbol": "BT1.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Building H (box 24)", "address2": "Rue GranbonprE 11", "city": "Mont-Saint-Guibert", "zip": "1435", "country": "Belgium", "phone": "32 493 09 73 66", "website": "https://www.biosenic.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "BioSenic S.A., a biotech company, focuses on developing clinical assets. Its technologies include cutting-edge allogeneic cell and gene therapy platform with differentiated bone marrow sourced mesenchymal stromal cells, which can be stored at the point of use in the hospital; and Arsenic TriOxide platform for use in immuno-oncology to treat graft-versus-host disease, systemic lupus erythematosus, and systemic sclerosis. The company's investigational medicinal product is ALLOB, which is in a Phase IIb clinical trial in patients with difficult tibial fractures. The company is based in Mont-Saint-Guibert, Belgium.", "companyOfficers": [{"maxAge": 1, "name": "Fran\u00e7ois  Rieger", "title": "CEO, Pres & Chairman", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Carole  Nicco", "title": "Chief Scientific Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. V\u00e9ronique  Pomi-Schneiter", "title": "Deputy CEO & Exec. Director", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Lieven  Huysse M.D.", "title": "Chief Medical Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}